ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	619.55	638.53	3,015	1,179	1,195	2,438
Short-Term Investments	630	630	630	4,547	120	96
Trading Asset Securities	2,652	410.72	5,769	2,901	1,465	308.11
Cash & Short-Term Investments	3,902	1,679	9,414	8,628	2,781	2,842
Cash Growth	1.84%	-82.16%	9.11%	210.28%	-2.17%	-
Accounts Receivable	3,392	2,930	1,596	1,873	3,497	1,733
Other Receivables	14.6	108.46	8.07	47.67	3.28	383.27
Receivables	3,407	3,039	1,604	2,321	3,500	2,117
Inventory	2,344	2,375	2,265	2,952	2,106	1,774
Prepaid Expenses	29.84	152.11	16.83	59.27	81.21	394.93
Other Current Assets	1,185	1,144	117.63	163.87	204.67	121.52
Total Current Assets	10,867	8,390	13,417	14,123	8,672	7,249
Property, Plant & Equipment	10,857	11,061	10,312	10,319	10,287	7,423
Long-Term Investments	1,935	1,923	1,585	6,491	1,878	3,938
Goodwill	704.45	704.45	1,126	-	-	-
Other Intangible Assets	866.11	898.15	1,029	2.4	5.11	11.94
Long-Term Accounts Receivable	-	-	-	-	0	0
Other Long-Term Assets	98.88	98.42	623.51	83	117.09	218.03
Total Assets	25,329	23,074	28,093	31,018	20,959	18,840
Accounts Payable	1,731	1,669	250.65	386.05	1,116	485.06
Accrued Expenses	185.4	585.44	212.78	250.12	341.01	401.94
Short-Term Debt	7,828	6,735	9,142	9,543	9,147	3,140
Current Portion of Long-Term Debt	703.94	653.96	399.08	166.56	773.78	55.45
Current Portion of Leases	55.98	60.72	89.38	21.09	19.92	24.95
Other Current Liabilities	4,374	3,797	1,174	1,426	1,229	1,387
Total Current Liabilities	14,878	13,501	11,268	11,793	12,626	5,495
Long-Term Debt	3,535	3,859	3,513	3,012	3,179	3,952
Long-Term Leases	398.92	413.32	466.24	28.1	49.18	65.3
Long-Term Deferred Tax Liabilities	476.96	483.29	205.32	-	-	-
Other Long-Term Liabilities	-	0	0	-	-	-
Total Liabilities	19,353	18,304	15,525	14,833	15,854	9,513
Common Stock	5,680	4,570	4,570	4,570	3,847	1,267
Additional Paid-In Capital	27,440	25,557	27,257	27,257	18,293	20,582
Retained Earnings	-24,750	-24,381	-16,431	-13,574	-16,270	-13,606
Comprehensive Income & Other	-884.55	-909.44	-2,004	-2,068	-763.03	1,084
Total Common Equity	7,486	4,837	13,393	16,185	5,106	9,327
Minority Interest	-2,094	-1,862	-2,545	-	-	-
Shareholders' Equity	5,975	4,771	12,569	16,185	5,106	9,327
Total Liabilities & Equity	25,329	23,074	28,093	31,018	20,959	18,840
Total Debt	12,522	11,722	13,610	12,771	13,168	7,238
Net Cash (Debt)	-8,620	-10,043	-4,196	-4,143	-10,388	-4,396
Net Cash Per Share	-930.47	-1098.73	-459.08	-410.96	-1351.57	-879.51
Filing Date Shares Outstanding	11.36	9.14	9.14	9.14	7.69	5
Total Common Shares Outstanding	11.36	9.14	9.14	9.14	7.69	5
Working Capital	-4,011	-5,111	2,149	2,330	-3,954	1,754
Book Value Per Share	658.98	529.16	1465.20	1770.73	663.67	1866.18
Tangible Book Value	5,915	3,234	11,237	16,183	5,100	9,316
Tangible Book Value Per Share	520.72	353.83	1229.37	1770.47	663.00	1863.79
Land	5,321	5,321	3,868	3,868	641.06	641.06
Buildings	4,159	4,192	4,323	4,455	4,586	4,491
Machinery	827.95	967.43	1,411	1,729	2,201	318.5
Construction In Progress	-	-	14.4	117.47	2,784	1,864

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.